-
Reports in Medical Imaging
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Effect of biologic agents on radiographic progression of rheumatoid arthritis
Review
(1827) Views (696) Full article downloads
Authors: Gabriel J Tobón, Alain Saraux, Valérie Devauchelle-Pensec
Published Date August 2010
Volume 2010:3 Pages 35 - 44
DOI: http://dx.doi.org/10.2147/RMI.S4665
Gabriel J Tobón1, Alain Saraux1,2, Valérie Devauchelle-Pensec1,21Immunology Laboratory, Morvan Hospital, Université de Bretagne Occidentale, Brest, France; 2Rheumatology Unit, Hôpital de la Cavale Blanche, CHU Brest, France
Abstract: The treatment of rheumatoid arthritis (RA) has benefited over the last few years from the introduction of biologic agents whose development was based on new insights into the immunological factors involved in the pathogenesis of RA and the development of joint damage. These biological agents have been proven effective in RA patients with inadequate responses to synthetic disease-modifying antirheumatic drugs (DMARDs). Preventing joint damage is now the primary goal of RA treatment, and guidelines exist for the follow-up of joint abnormalities. Most biologic agents produced high clinical and radiological response rates in patients with established or recent-onset RA. Thus, for the first time, obtaining a remission is a reasonable treatment goal in RA patients. Factors that are crucial to joint damage control are: early initiation of DMARDs, use of intensive treatments including biological agents, and close monitoring of clinical disease activity and radiographic progression. However, some patients remain unresponsive to all available treatments and continue to experience joint damage progression. A major objective now is to identify patients at high risk for severe joint damage, in order to tailor the treatment regimen to their specific needs.
Keywords: rheumatoid arthritis, radiographic progression, biologics
Readers of this article also read:
An appraisal of ultrasound fetal biometry in the first trimester
Besilesomab for imaging inflammation and infection in peripheral bone in adults with suspected osteomyelitis
Effective ultrasonic virtual sources which can be positioned independently of physical aperture focus positions
Utilization of an ultrasound beam steering angle for measurements of tissue displacement vector and lateral displacement
Multidetector computed tomography in acute lower gastrointestinal bleeding
Study of optimal exposure windows using 320-Detector rows dynamic volume CT
Cardiac MRI detection of a rare case of familial cardiac amyloidosis (Ser23Asn): case report with literature review
Secondary infertility in women: radiologic evaluation
Erratum
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Imaging of peripheral vascular disease
- Capillary telangiectasia mimicking an active inflammatory MS-lesion in repetitive cMRIs
- Comparison of a new PillCam™ SB2 video capsule versus the standard PillCam™ SB for detection of small bowel disease
- F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)-positive parotid incidentaloma: Prevalence and clinical significance




